The DOI matches its Crossref record.
Complexity of expression of antigenic determinants, recognized by monoclonal antibodies HMFG-1 and HMFG-2, in normal and malignant human mammary epithelial cells.
Abstract
The monoclonal antibodies HMFG-1 and HMFG-21 are produced by hybridomas derived by fusing spleen cells of mice immunized with delipidated preparations of the human milk fat globule. Enzyme-linked immunosorbent (ELISA) assays of Western blots prepared from gels separating components of the milk fat globule showed that both antibodies recognize determinants fouinn dh igh molecular weight components (>400K). Lectin-blocking experiments indicated that both antibodies recognizeo ligosaccharide sequences containing galactose, N-acetyl glucosamine, and, possibly, N-acetyl galactosamine. However, the determinant recognized by HMFG-1 is different from the determinant recognbizye dH MFG-2,w hich may contain or be adjacent to a nonterminal sialic acid residue. The expression of these antigenic determinants by normal mammary epithelial cells cultured from milk (HumE) and by a breast cancer cell line (T47D), was studied. In a live cell, radioimmune assay lower levels of HMFG-1 than HMFG-2 were required for effective binding to HumE cells, whereas HMFG-2 bound to T47D cells at lower concentrations than HMFG-1. Kinetic experiments using 125I-Iabeled antibodies showed that high affinity binding sites for both antibodies are present on HumE cells, but the number of sites binding HMFG-1 is greater than the number of sites binding HMFG-2. Thkei netics of dissociation of labeled antibodies from T47D cells sug gested the presenceo f several sites with different affinities for each antibody. Only in the case of HMFG-2 did some of these sites show a high affinity for the antibody. Western blots of gel-separated components of cell lysates when reacted in an ELISA assay showed that HMFG- 1r eacted with high molecular weight compoinn eHnutms E cells similar to those seen in the HMFG preparation. In contrast, high affinity sites for HMFG-2 were expressed by HumE and T47D on several components of lower molecular weight. All other breast carcinoma lines examined and metastatic cells from two breast cancer patients expressed high affinity binding sites for HMFG-2 on components of varying size (80K to >400K). Only two of five cell lines and cancer cells from one of the two patients expressed high affinity sites for HMFG-1 and these were found on high molecular weight glycoprotein(s3 00-400K). The results are consistent with the interpretation that the HMFG-1 determinant is present in large glycoprotein molecules with complex carbohydrate side chains, and the HMFG-2 determinant is more commonly found in smaller molecules where glycosylation may be incomplete and sialic acid residues more exposed. The preferential binding of HMFG-2 to some breast cancers may therefore reflect a changed glycosylation patteirnn these cells.
Overview
The claims and statistics of this paper haven’t been checked yet.
Run the check — free, no account needed. It reads the open-access text and checks the sources it cites.
Integrity signals
Registry
Cites
Statistics
Verification
Claims the paper makes
The claims and statistics of this paper haven’t been checked yet.
Run the check — free, no account needed. It reads the open-access text and checks the sources it cites.
Self-check
Percentages, sums and reported differences re-computed from the paper’s own numbers.
The self-check needs the paper’s full text.
Citations
Cited by
Mucins in cancer: protection and control of the cell surface
Hollingsworth, M. A., & Swanson, B. J. (2004) · Nature Reviews Cancer · doi:10.1038/nrc1251 · Cited by 1,807
Aberrant Glycosylation In Tumors And Tumor-Associated Carbohydrate Antigens
(1989) · Advances in Cancer Research · doi:10.1016/s0065-230x(08)60215-8 · Cited by 1,087
Comparative Study of Human and Rat Mammary Tumorigenesis
Russo, J., Gusterson, B. A., Rogers, A. E., Russo, I. H., Wellings, S. R., & Van Zwieten, M. J. (1990) · Pathology Reviews • 1990 · doi:10.1007/978-1-4612-0485-5_15 · Cited by 582
Gendler, S., Taylor-Papadimitriou, J., Duhig, T., Rothbard, J., & Burchell, J. (1988) · Journal of Biological Chemistry · doi:10.1016/s0021-9258(18)37632-4 · Cited by 568
Self-citationWilkie, S., van Schalkwyk, M. C. I., Hobbs, S., Davies, D. M., van der Stegen, S. J. C., Pereira, A. C. P., Burbridge, S. E., Box, C., Eccles, S. A., & Maher, J. (2012) · Journal of Clinical Immunology · doi:10.1007/s10875-012-9689-9 · Cited by 478
Alterations in glycosylation as biomarkers for cancer detection
Reis, C. A., Osorio, H., Silva, L., Gomes, C., & David, L. (2010) · Journal of Clinical Pathology · doi:10.1136/jcp.2009.071035 · Cited by 432
Characterization of bipotent mammary epithelial progenitor cells in normal adult human breast tissue
Stingl, J., Eaves, C. J., Zandieh, I., & Emerman, J. T. (2001) · Breast Cancer Research and Treatment · doi:10.1023/a:1010615124301 · Cited by 367
Molecular cloning of cDNAs derived from a novel human intestinal mucin gene
Gum, J. R., Hicks, J. W., Swallow, D. M., Lagace, R. L., Byrd, J. C., Lamport, D. T. A., Siddiki, B., & Kim, Y. S. (1990) · Biochemical and Biophysical Research Communications · doi:10.1016/0006-291x(90)91408-k · Cited by 360
Schroeder, J. A., Thompson, M. C., Gardner, M. M., & Gendler, S. J. (2001) · Journal of Biological Chemistry · doi:10.1074/jbc.m011248200 · Cited by 346
Mammosphere culture of metastatic breast cancer cells enriches for tumorigenic breast cancer cells
Grimshaw, M. J., Cooper, L., Papazisis, K., Coleman, J. A., Bohnenkamp, H. R., Chiapero-Stanke, L., Taylor-Papadimitriou, J., & Burchell, J. M. (2008) · Breast Cancer Research · doi:10.1186/bcr2106 · Cited by 339
Self-citationMiotti, S., Canevari, S., Ménard, S., Mezzanzanica, D., Porro, G., Pupa, S. M., Regazzoni, M., Tagliabue, E., & Colnaghi, M. I. (1987) · International Journal of Cancer · doi:10.1002/ijc.2910390306 · Cited by 315
Gendler, S. J., Burchell, J. M., Duhig, T., Lamport, D., White, R., Parker, M., & Taylor-Papadimitriou, J. (1987) · Proceedings of the National Academy of Sciences · doi:10.1073/pnas.84.17.6060 · Cited by 289
Self-citationMUC1 mucin expression as a marker of progression and metastasis of human colorectal carcinoma
Nakamori, S., Ota, D. M., Cleary, K. R., Shirotani, K., & Irimura, T. (1994) · Gastroenterology · doi:10.1016/0016-5085(94)90592-4 · Cited by 280
MUC‐1 Epithelial Tumor Mucin‐Based Immunity and Cancer Vaccines
Finn, O. J., Jerome, K. R., Henderson, R. A., Pecher, G., Domenech, N., Magarian‐Blander, J., & Barratt‐Boyes, S. M. (1995) · Immunological Reviews · doi:10.1111/j.1600-065x.1995.tb00077.x · Cited by 261
Cyster, J. G., Shotton, D. M., & Williams, A. F. (1991) · The EMBO Journal · doi:10.1002/j.1460-2075.1991.tb08022.x · Cited by 259
Stingl, J., Eaves, C. J., Kuusk, U., & Emerman, J. T. (1998) · Differentiation · doi:10.1046/j.1432-0436.1998.6340201.x · Cited by 252
Band, V, & Sager, R. (1989) · Proceedings of the National Academy of Sciences · doi:10.1073/pnas.86.4.1249 · Cited by 194
Metadata
- Authors
- Burchell, J., Durbin, H., & Taylor-Papadimitriou, J.
- Venue
- The Journal of Immunology
- Publisher
- Oxford University Press (OUP)
- Published
- 1983-07-01
- Volume
- 131
- Issue
- 1
- Pages
- 508-513
- ISSN
- 0022-1767 (ISSN-L)
- 1550-6606
- OpenAlex
- W2294334808
- Cited by
- 333
- References
- 0
- FWCI
- 9.81
- Type
- journal article
- Language
- en
- Open access
- closed
About these checks
Registry, retraction, Cites and statistics results are computed, not judged, with one exception: a printed reference that no index lists is read once by a model before it counts as a citation error. Claims are extracted by a model and kept only when their quote appears verbatim in the text; each cited source is then checked, with a model’s help, for whether it says what the claim relies on. Those verdicts can be wrong — read the claim’s quote and the cited source before relying on one.
Statistics and arithmetic are recomputed, not judged.
Confidence bands are shown only for fields calibrated on our annotated test set. None is calibrated yet, so no band is shown.
What counts as a claim ›How we measure confidence ›How we check this ›
Are you an author, or do you see a problem with this page? Request a review
Data sources
Bibliographic data: Semantic Scholar, OpenAlex, Crossref.
Contains information from the Semantic Scholar Academic Graph Datasets, made available under the ODC Attribution License (ODC-BY 1.0).
Semantic Scholar’s data is described in: Kinney, R., et al. (2023). The Semantic Scholar Open Data Platform. arXiv:2301.10140.